The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 14, 2010

Filed:

Sep. 04, 2009
Applicants:

Sean Stevens, Mohegan Lake, NY (US);

Tammy T. Huang, Golden Bridge, NY (US);

Joel H. Martin, Putnam Valley, NY (US);

Jeanette L. Fairhurst, White Plains, NY (US);

Ashique Rafique, Yonkers, NY (US);

Marcela Torres, New Milford, NJ (US);

Kevin J. Pobursky, Beacon, NY (US);

Raymond W. Leidich, Middletown, NY (US);

Joan A. Windsor, Brooklyn, NY (US);

Warren R. Mikulka, Brewster, NY (US);

Diana M. Ahrens, Mahopac, NY (US);

Ergang Shi, Ossining, NY (US);

Nicholas J. Papadopoulos, LaGrangeville, NY (US);

Inventors:

Sean Stevens, Mohegan Lake, NY (US);

Tammy T. Huang, Golden Bridge, NY (US);

Joel H. Martin, Putnam Valley, NY (US);

Jeanette L. Fairhurst, White Plains, NY (US);

Ashique Rafique, Yonkers, NY (US);

Marcela Torres, New Milford, NJ (US);

Kevin J. Pobursky, Beacon, NY (US);

Raymond W. Leidich, Middletown, NY (US);

Joan A. Windsor, Brooklyn, NY (US);

Warren R. Mikulka, Brewster, NY (US);

Diana M. Ahrens, Mahopac, NY (US);

Ergang Shi, Ossining, NY (US);

Nicholas J. Papadopoulos, LaGrangeville, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides methods for treating one or more diseases or disorders which are improved, inhibited or ameliorated by reducing interleukin-4 (IL-4) activity. The methods of the invention comprise administering to a patient an antibody, or antigen-binding fragment thereof, which specifically binds to a human IL-4 receptor.


Find Patent Forward Citations

Loading…